These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 32716227)

  • 41. Impact of age on pathological complete response and locoregional recurrence in locally advanced breast cancer after neoadjuvant chemotherapy.
    Chou HH; Kuo WL; Yu CC; Tsai HP; Shen SC; Chu CH; Yu MC; Lo YF; Dabora MA; Chang HK; Lin YC; Ueng SH; Chen SC
    Biomed J; 2019 Feb; 42(1):66-74. PubMed ID: 30987708
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Margins in Breast-Conserving Surgery After Neoadjuvant Therapy.
    Choi J; Laws A; Hu J; Barry W; Golshan M; King T
    Ann Surg Oncol; 2018 Nov; 25(12):3541-3547. PubMed ID: 30128902
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The role of postmastectomy radiotherapy in clinically node-positive, stage II-III breast cancer patients with pathological negative nodes after neoadjuvant chemotherapy: an analysis from the NCDB.
    Liu J; Mao K; Jiang S; Jiang W; Chen K; Kim BY; Liu Q; Jacobs LK
    Oncotarget; 2016 Apr; 7(17):24848-59. PubMed ID: 26709538
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A nomogram for predicting locoregional recurrence in primary breast cancer patients who received breast-conserving surgery after neoadjuvant chemotherapy.
    Matsuda N; Hayashi N; Ohde S; Yagata H; Kajiura Y; Yoshida A; Suzuki K; Nakamura S; Tsunoda H; Yamauchi H
    J Surg Oncol; 2014 Jun; 109(8):764-9. PubMed ID: 24647874
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Omitting radiotherapy in women ≥ 65 years with low-risk early breast cancer after breast-conserving surgery and adjuvant endocrine therapy is safe.
    Wickberg Å; Liljegren G; Killander F; Lindman H; Bjöhle J; Carlberg M; Blomqvist C; Ahlgren J; Villman K
    Eur J Surg Oncol; 2018 Jul; 44(7):951-956. PubMed ID: 29709338
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Radiotherapy after breast-conserving surgery for elderly patients with early-stage breast cancer: A national registry-based study.
    Wang F; Meszoely I; Pal T; Mayer IA; Bailey CE; Zheng W; Shu XO
    Int J Cancer; 2021 Feb; 148(4):857-867. PubMed ID: 32838477
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Standard Pathologic Features Can Be Used to Identify a Subset of Estrogen Receptor-Positive, HER2 Negative Patients Likely to Benefit from Neoadjuvant Chemotherapy.
    Petruolo OA; Pilewskie M; Patil S; Barrio AV; Stempel M; Wen HY; Morrow M
    Ann Surg Oncol; 2017 Sep; 24(9):2556-2562. PubMed ID: 28560596
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Survival of Breast-Conserving Surgery Plus Radiotherapy versus Total Mastectomy in Early Breast Cancer.
    Kim H; Lee SB; Nam SJ; Lee ES; Park BW; Park HY; Lee HJ; Kim J; Chung Y; Kim HJ; Ko BS; Lee JW; Son BH; Ahn SH
    Ann Surg Oncol; 2021 Sep; 28(9):5039-5047. PubMed ID: 33492542
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The impact of adjuvant radiotherapy on the survival of primary breast cancer patients: a retrospective multicenter cohort study of 8935 subjects.
    Wöckel A; Wolters R; Wiegel T; Novopashenny I; Janni W; Kreienberg R; Wischnewsky M; Schwentner L;
    Ann Oncol; 2014 Mar; 25(3):628-632. PubMed ID: 24515935
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prognostic value of lymphocytes in patients with breast cancer receiving radiotherapy after breast-conserving surgery: A post hoc analysis of a phase III randomized trial.
    Song YC; Chen SY; Zhao XR; Jing H; Fang H; Tang Y; Hu SY; Song YW; Jin J; Liu YP; Qi SN; Sun GY; Zhong QZ; Du XH; Liu J; Li YX; Wang SL
    Radiother Oncol; 2024 Oct; 199():110390. PubMed ID: 38897316
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Adjuvant breast radiotherapy, endocrine therapy, or both after breast conserving surgery in older women with low-risk breast cancer: Results from a population-based study.
    Joseph K; Zebak S; Alba V; Mah K; Au C; Vos L; Ghosh S; Abraham A; Chafe S; Wiebe E; Liu HW; Chambers C; Gabos Z; Tankel K; Lupichuk S; King K
    Radiother Oncol; 2021 Jan; 154():93-100. PubMed ID: 32941956
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Oncological outcome of complete response after neoadjuvant chemotherapy for breast conserving surgery: a systematic review and meta-analysis.
    Li X; Dai D; Chen B; Tang H; Wei W
    World J Surg Oncol; 2017 Nov; 15(1):210. PubMed ID: 29183336
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Targeted Intraoperative Radiotherapy Tumour Bed Boost During Breast Conserving Surgery after Neoadjuvant Chemotherapy in HER2 Positive and Triple Negative Breast Cancer.
    Kolberg HC; Loevey G; Akpolat-Basci L; Stephanou M; Fasching PA; Untch M; Bulsara M; Vaidya JS; Liedtke C
    Rev Recent Clin Trials; 2017; 12(2):93-100. PubMed ID: 28155607
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Contralateral Prophylactic Mastectomy Use After Neoadjuvant Chemotherapy.
    Christian N; Zabor EC; Cassidy M; Flynn J; Morrow M; Gemignani ML
    Ann Surg Oncol; 2020 Mar; 27(3):743-749. PubMed ID: 31732944
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Association of Circulating Tumor Cell Status With Benefit of Radiotherapy and Survival in Early-Stage Breast Cancer.
    Goodman CR; Seagle BL; Friedl TWP; Rack B; Lato K; Fink V; Cristofanilli M; Donnelly ED; Janni W; Shahabi S; Strauss JB
    JAMA Oncol; 2018 Aug; 4(8):e180163. PubMed ID: 29800954
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Patient views and correlates of radiotherapy omission in a population-based sample of older women with favorable-prognosis breast cancer.
    Shumway DA; Griffith KA; Hawley ST; Wallner LP; Ward KC; Hamilton AS; Morrow M; Katz SJ; Jagsi R
    Cancer; 2018 Jul; 124(13):2714-2723. PubMed ID: 29669187
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Axillary dissection in breast-conserving surgery for stage I and II breast cancer: a National Cancer Data Base study of patterns of omission and implications for survival.
    Bland KI; Scott-Conner CE; Menck H; Winchester DP
    J Am Coll Surg; 1999 Jun; 188(6):586-95; discussion 595-6. PubMed ID: 10359351
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Role of 21-Gene Recurrence Score in Predicting Prognostic Benefit of Radiation Therapy After Breast-Conserving Surgery for T1N0 Breast Cancer.
    Chevli N; Haque W; Tran KT; Farach AM; Schwartz MR; Hatch SS; Butler EB; Teh BS
    Pract Radiat Oncol; 2023; 13(3):e230-e238. PubMed ID: 36038115
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Adjuvant radiation therapy and survival for adenoid cystic carcinoma of the breast.
    Sun JY; Wu SG; Chen SY; Li FY; Lin HX; Chen YX; He ZY
    Breast; 2017 Feb; 31():214-218. PubMed ID: 27915203
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Combination of breast imaging parameters obtained from
    Grapin M; Coutant C; Riedinger JM; Ladoire S; Brunotte F; Cochet A; Humbert O
    Eur J Radiol; 2019 Apr; 113():81-88. PubMed ID: 30927964
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.